This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Deken, X.
Right arrow Articles by Raymond, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Deken, X.
Right arrow Articles by Raymond, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2004, p. 2700-2703, Vol. 48, No. 7
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.7.2700-2703.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2

Xavier De Deken and Martine Raymond*

Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada H2W 1R7

Received 4 December 2003/ Returned for modification 7 January 2004/ Accepted 8 March 2004

Candida albicans azole-resistant clinical isolates overexpressing the CDR1 and CDR2 genes (multidrug transporters) also overexpress the PDR16 gene (phosphatidylinositol transfer protein). We show here that the PDR16 promoter displays higher transcriptional activity following integration in an azole-resistant isolate than in the matched azole-susceptible one. Thus, the upregulation of PDR16 in the resistant strain results from a mutation acting in trans.


* Corresponding author. Mailing address: Institut de Recherches Cliniques de Montréal, 110 Pine Ave. West, Montréal, Québec, Canada H2W 1R7. Phone: 514-987-5770. Fax: 514-987-5764. E-mail: raymonm{at}ircm.qc.ca.


Antimicrobial Agents and Chemotherapy, July 2004, p. 2700-2703, Vol. 48, No. 7
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.7.2700-2703.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Coste, A. T., Crittin, J., Bauser, C., Rohde, B., Sanglard, D. (2009). Functional Analysis of cis- and trans-Acting Elements of the Candida albicans CDR2 Promoter with a Novel Promoter Reporter System. Eukaryot Cell 8: 1250-1267 [Abstract] [Full Text]  
  • Znaidi, S., Weber, S., Zin Al-Abdin, O., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F., Raymond, M. (2008). Genomewide Location Analysis of Candida albicans Upc2p, a Regulator of Sterol Metabolism and Azole Drug Resistance. Eukaryot Cell 7: 836-847 [Abstract] [Full Text]  
  • Liu, T. T., Znaidi, S., Barker, K. S., Xu, L., Homayouni, R., Saidane, S., Morschhauser, J., Nantel, A., Raymond, M., Rogers, P. D. (2007). Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon. Eukaryot Cell 6: 2122-2138 [Abstract] [Full Text]  
  • Coste, A., Turner, V., Ischer, F., Morschhauser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., Sanglard, D. (2006). A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans. Genetics 172: 2139-2156 [Abstract] [Full Text]  
  • Cheng, G., Yeater, K. M., Hoyer, L. L. (2006). Cellular and Molecular Biology of Candida albicans Estrogen Response. Eukaryot Cell 5: 180-191 [Abstract] [Full Text]  
  • Cao, Y.-Y., Cao, Y.-B., Xu, Z., Ying, K., Li, Y., Xie, Y., Zhu, Z.-Y., Chen, W.-S., Jiang, Y.-Y. (2005). cDNA Microarray Analysis of Differential Gene Expression in Candida albicans Biofilm Exposed to Farnesol. Antimicrob. Agents Chemother. 49: 584-589 [Abstract] [Full Text]